Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via β1 integrin-mediated survival signals

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 599-606

  Mooney, Andrew ^a   Jackson, Kathryn ^a   Bacon, Rachel ^a   Streuli, Charles ^b   Edwards, Gwynneth ^b   Bassuk, Jim ^c   Savill, John ^a,d  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; INTEGRIN; LAMININ; PROTEIN BCL 2; SCLEROPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GLOMERULITIS; GLOMERULOSCLEROSIS; KIDNEY DISEASE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0032814264     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65155-3     Document Type: Article

References (43)

1. Border WA, Ruoslahti E: Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992, 90:1-7
2. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996, 49:103-111
3. Couchman JR, Bevan LA, McCarthy KJ: Glomerular matrix: synthesis turnover and role in mesangial expansion. Kidney Int 1994, 45:328-335
4. Meredith J, Fazeli B, Schwartz M: The extracellular matrix as a survival factor. Mol Biol Cell 1993, 4:953-961
5. Bates RC, Buret A, Van Helden DF, Horton MA, Burns GF: Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994, 125: 403-415
6. Frisch SM, Harris H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626
7. Brooks P, Montgomery AMP, Rosenfield M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164
8. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995, 276:891-892
9. Zhang Z, Vuori K, Reed JC, Ruoslahti E: The α5β1 integrin supports survival of cells on fibronectin, and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995, 92:6161-6165
10. 1 integrin expression results in reduced cyst formation, failure of hepatocyte growth-factor scatter factor-induced branching morphogenesis, and increased apoptosis. J Cell Sci 1995, 108:3531-3540
11. 5 subunit in HT29 colon-carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp Cell Res 1996, 224:208-213
12. Pullan S, Wilson J, Metcalfe A, Edwards GM, Goberdhan N, Tilly J, Hickman JA, Dive C, Streuli CH: Requirement of basement-membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 1996, 109:631-642
13. Johnson R: The glomerular response to injury: progression or resolution? Kidney Int 1994, 45:1769-1782
14. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE: Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest 1991, 64:446-456
15. Mene P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 1989, 69:1374-1424
16. Abboud HE: Nephrology forum: growth factors in glomerulonephritis. Kidney Int 1993, 43:252-267
17. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994, 94:2105-2116
18. Singhal PC, Hays RM: Actin filament morphology in living and non-living cultured mesangial cells: formation and dissolution. Nephron 1988, 50:28-33
19. Singhal PC, Franki N, Kumari S, Sanwal V, Wagner JD, Mattana J: Extracellular matrix modulates mesangial cell apoptosis and mRNA expression of cathepsin-B and tissue transglutaminase. J Cell Biochem 1998, 68:22-30
20. Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H: Regulation of survival and death of mesangial cells by extracellular matrix. Kidney Int 1998, 54:1188-1196
21. Mooney A, Jobson T, Bacon R, Kitamura M, Savill J: Cytokines regulate glomerular mesangial cell survival by stimulus-dependent inhibition of apoptosis. J Immunol 1997, 159:3949-3960
22. Yokoo T, Kitamura M: IL-1β depresses expression of the 70-kilodalton heat shock protein and sensitises glomerular cells to oxidant-initiated apoptosis. J Immunol 1997, 159:2886-2892
23. Kitamura M, Kawachi H: Creation of an in vivo cytosensor using engineered mesangial cells. J Clin Invest 1997, 100:13941399
24. Savill JS, Smith J, Ren Y, Sarraf C, Abbott F, Rees AJ: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 1992, 42:924-936
25. Lovett DH, Sterzel RB: Cell culture approaches to the analysis of glomerular inflammation. Kidney Int 1986, 30:246-254
26. Bassuk JA, Braun LP, Motamed K, Baneyx F, Sage EH: Renaturation of SPARC expressed in Escherichia coli requires isomerization of disulfide bonds for recovery of biological activity. Int J Biochem Cell Biol 1996, 28:1031-1043
27. Bassuk JA, Baneyx F, Vernon RB, Funk SE, Sage EH: Expression of biologically active human SPARC in Escherichia coli. Arch Biochem Biophys 1996, 325:8-19
28. Pichler R, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ: SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated cell proliferation in vitro. Am J Pathol 1996, 148:1153-1167
29. Henson PM, Johnston RB: Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1987, 79:669-674
30. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
31. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995, 92:7834-7838
32. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pert S, Grundy JE, Janossy G: The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infection: the role of apoptosis in T cell memory. J Exp Med 1993, 178:427
33. Ruoslahti E, Pierschbacher MD: Arg-Gly-Asp: a versatile cell recognition signal. Cell 1986, 44:517-518
34. Hafdi Z, Lesavre P, Tharaux PL, Bessou G, Baruch D, Halbwachs-Mecarelli L: Role of a (V) integrins in mesangial cell adhesion to vitronectin and von Willebrand factor. Kidney Int 1997, 51:1900-1907
35. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH: Complementation of dominant suppression implicates CD98 in integrin activation. Nature 1997, 390:81-85
36. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: α3β1 integrin has a crucial role in kidney and lung organogenesis. Development 1996, 122:3537-3547
37. Milner R, Wilby M, Nishimura S, Boylen K, Edwards G, Fawcett J, Streuli C, Pytela R, Constant C: Division of labor of Schwann cell integrins during migration on peripheral nerve extracellular matrix ligands. Dev Biol 1997, 185:215-228
38. Edwards GM, Streuli CH: Preparing a polyclonal antibody to mouse ss1 integrin with function-blocking activity. Integrin Protocols. Methods in Molecular Biology, vol. 129. Edited by A Hewlett. Totowa, NJ, Humana Press, 1999, pp 135-152
39. Mendrick DL, Kelly DM, duMont SS, Sandstrom DJ: Glomerular epithelial and mesangial cells differentially modulate the binding specificities of VLA-1 and VLA-2. Lab Invest 1995, 72:367-375
40. Falk-Marzillier J, Domanico SZ, Pelletier A, Mullen L, Quarante V: Characterization of a tight molecular complex between integrin α6β4 and laminin-5 extracellular matrix. Biochem Biophys Res COmmun 1998, 251:49-55
41. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers CE, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992, 175:1413-1416
42. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against growth factor-β. Nature 1990, 346:371-374
43. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992, 360:361-364